Document
IPR2018-00119, No. 2001-15 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2001-15 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2017-30 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 20...
Cite Document
IPR2018-00119, No. 2017-30 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2009-23 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2009-23 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2015-29 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2015-29 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2007-21 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2007-21 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2006-20 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2006-20 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2008-22 Exhibit - I MAK Our People (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2008-22 Exhibit - I MAK Our People (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2019-31 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2019-31 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2010-24 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2010-24 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2¿¿¿ C Methylcytidine (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2¿¿¿ C Methylcytidine (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2009-23 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2009-23 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2003-17 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2003-17 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2017-29 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 20...
Cite Document
IPR2018-00120, No. 2017-29 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2012-26 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2012-26 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2005-19 Exhibit - Hepatitis C Killing More Americans than HIV Studies (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2005-19 Exhibit - Hepatitis C Killing More Americans than HIV Studies (P.T.A.B. Feb. 8, 2018)
+ More Snippets